What is next after anamorelin?

  • José Ma García
  • Published 2017 in Current opinion in supportive and palliative care


PURPOSE OF REVIEW In spite of its relevance, treatments for the cancer anorexia and cachexia syndrome (CACS) are not available. One of the agents that recently reached phase III clinical trials is anamorelin. Its development, along with that of other agents for this indication, will be reviewed here, with a focus on the gaps in the current knowledge and… (More)
DOI: 10.1097/SPC.0000000000000299


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics